Andrew Mok analyst BARCLAYS

Currently out of the existing stock ratings of Andrew Mok, 41 are a SELL (10.85%), 133 are a HOLD (35.19%), 204 are a BUY (53.97%).

Andrew Mok

Work Performance Price Targets & Ratings Chart

Analyst Andrew Mok, currently employed at BARCLAYS, has had 64.26% of price targets met with an average potential upside of 16.35%, reached in 152 days on average.

Andrew Mok has documented 760 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on HUM, Humana.

Wall Street Analyst Andrew Mok

Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for DVA (DAVITA HEALTHCARE PARTNERS) on 2/2/2026. The price target of $143 was fulfilled within 3 days with a profit of $31.81 (28.61%), with a performance score of 95.36.

Average potential price target upside

AMED Amedisys CYH Community Health Systems THC Tenet Healthcare UHS Universal Health Services EHC Encompass Health Corp HCA HCA Holdings ACHC Acadia Healthcare Company LHCG LHC Group OSH Oak Street Health DVA DaVita HealthCare Partners CANO Cano Health CMAX CareMax EHAB Enhabit PRVA Privia Health Group ALHC Alignment Healthcare LLC CI Cigna Corp CNC Centene Corp CVS CVS Health Corp ELV Elevance Health HUM Humana MOH Molina Healthcare RDNT RadNet ADUS Addus HomeCare AGL agilon health AVAH Aveanna Healthcare Holdings OSCR Oscar Health SGRY Surgery Partners UNH UnitedHealth Group BKD Brookdale Senior Living AME Ametek ASTH Astrana Health LH Laboratory of America Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Feb-2023

$100

$100

1 years 7 months 1 days ago
(16-Apr-2025)

3/4 (75%)

$8.09 (8.80%)

347

Hold Since 21-Apr-2023

$101

$101

1 years 7 months 13 days ago
(04-Apr-2025)

2/9 (22.22%)

$9.11 (9.91%)

419

Hold Since 26-Mar-2024

1 years 8 months 7 days ago
(10-Mar-2025)

6/11 (54.55%)

$12.13 (9.49%)

97

Hold Since 21-Oct-2019

$101

$91

1 years 8 months 13 days ago
(04-Mar-2025)

6/13 (46.15%)

$8.9 (9.66%)

25

Buy Since 03-Aug-2018

$100

$139

1 years 10 months 18 days ago
(30-Dec-2024)

8/14 (57.14%)

$9.51 (10.51%)

89

Show more analysts

Please expand the browser size to see the chart

Which stock is Andrew Mok most bullish on?

Potential upside of $137 has been obtained for HUM (HUMANA)

Which stock is Andrew Mok most reserved on?

Potential downside of -$98.05 has been obtained for HCA (HCA HOLDINGS)

What Year was the first public recommendation made by Andrew Mok?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?